Identification and validation of bioactive small molecule target through phenotypic screening

Yoon Sun Cho; Ho Jeong Kwon

doi:10.1016/j.bmc.2011.11.021

Identification and validation of bioactive small molecule target through phenotypic screening

Yoon Sun Cho, Ho Jeong Kwon

Research output: Contribution to journal › Article › peer-review

28 Citations (Scopus)

Abstract

For effective bioactive small molecule discovery and development into new therapeutic drug, a systematic screening and target protein identification is required. Different from the conventional screening system, herein phenotypic screening in combination with multi-omics-based target identification and validation (MOTIV) is introduced. First, phenotypic screening provides visual effect of bioactive small molecules in the cell or organism level. It is important to know the effect on the cell or organism level since small molecules affect not only a single target but the entire cellular mechanism within a cell or organism. Secondly, MOTIV provides systemic approach to discover the target protein of bioactive small molecule. With the chemical genomics and proteomics approach of target identification methods, various target protein candidates are identified. Then network analysis and validations of these candidates result in identifying the biologically relevant target protein and cellular mechanism. Overall, the combination of phenotypic screening and MOTIV will provide an effective approach to discover new bioactive small molecules and their target protein and mechanism identification.

Original language	English
Pages (from-to)	1922-1928
Number of pages	7
Journal	Bioorganic and Medicinal Chemistry
Volume	20
Issue number	6
DOIs	https://doi.org/10.1016/j.bmc.2011.11.021
Publication status	Published - 2012 Mar 15

Bibliographical note

Funding Information:
The authors express their gratitude to Drs. Peter Karuso and James Chen for critical comments and members of chemical genomics NRL at Yonsei University. This study was partly supported by grants from the National Research Foundation (NRF) of Korea , the Korean Government (MEST; 2009-0092964, 2010-0017984, F01-2009-000-10183-0), the Translational Research Center for Protein Function Control and the National Junior Research Fellowship , NRF (2009-0083522, 2011-006165), the Center for Food and Drug Materials of Agriculture Science & Technology Development (2011-8-1178), the Rural Development Administration , and the Brain Korea 21 Project.

All Science Journal Classification (ASJC) codes

Biochemistry
Molecular Medicine
Molecular Biology
Pharmaceutical Science
Drug Discovery
Clinical Biochemistry
Organic Chemistry

Access to Document

10.1016/j.bmc.2011.11.021

Cite this

@article{9dab8f996cd848dcabd11f4a718152b0,

title = "Identification and validation of bioactive small molecule target through phenotypic screening",

abstract = "For effective bioactive small molecule discovery and development into new therapeutic drug, a systematic screening and target protein identification is required. Different from the conventional screening system, herein phenotypic screening in combination with multi-omics-based target identification and validation (MOTIV) is introduced. First, phenotypic screening provides visual effect of bioactive small molecules in the cell or organism level. It is important to know the effect on the cell or organism level since small molecules affect not only a single target but the entire cellular mechanism within a cell or organism. Secondly, MOTIV provides systemic approach to discover the target protein of bioactive small molecule. With the chemical genomics and proteomics approach of target identification methods, various target protein candidates are identified. Then network analysis and validations of these candidates result in identifying the biologically relevant target protein and cellular mechanism. Overall, the combination of phenotypic screening and MOTIV will provide an effective approach to discover new bioactive small molecules and their target protein and mechanism identification.",

author = "Cho, {Yoon Sun} and Kwon, {Ho Jeong}",

note = "Funding Information: The authors express their gratitude to Drs. Peter Karuso and James Chen for critical comments and members of chemical genomics NRL at Yonsei University. This study was partly supported by grants from the National Research Foundation (NRF) of Korea , the Korean Government (MEST; 2009-0092964, 2010-0017984, F01-2009-000-10183-0), the Translational Research Center for Protein Function Control and the National Junior Research Fellowship , NRF (2009-0083522, 2011-006165), the Center for Food and Drug Materials of Agriculture Science & Technology Development (2011-8-1178), the Rural Development Administration , and the Brain Korea 21 Project.",

year = "2012",

month = mar,

day = "15",

doi = "10.1016/j.bmc.2011.11.021",

language = "English",

volume = "20",

pages = "1922--1928",

journal = "Bioorganic and Medicinal Chemistry",

issn = "0968-0896",

publisher = "Elsevier Limited",

number = "6",

}

TY - JOUR

T1 - Identification and validation of bioactive small molecule target through phenotypic screening

AU - Cho, Yoon Sun

AU - Kwon, Ho Jeong

N1 - Funding Information: The authors express their gratitude to Drs. Peter Karuso and James Chen for critical comments and members of chemical genomics NRL at Yonsei University. This study was partly supported by grants from the National Research Foundation (NRF) of Korea , the Korean Government (MEST; 2009-0092964, 2010-0017984, F01-2009-000-10183-0), the Translational Research Center for Protein Function Control and the National Junior Research Fellowship , NRF (2009-0083522, 2011-006165), the Center for Food and Drug Materials of Agriculture Science & Technology Development (2011-8-1178), the Rural Development Administration , and the Brain Korea 21 Project.

PY - 2012/3/15

Y1 - 2012/3/15

N2 - For effective bioactive small molecule discovery and development into new therapeutic drug, a systematic screening and target protein identification is required. Different from the conventional screening system, herein phenotypic screening in combination with multi-omics-based target identification and validation (MOTIV) is introduced. First, phenotypic screening provides visual effect of bioactive small molecules in the cell or organism level. It is important to know the effect on the cell or organism level since small molecules affect not only a single target but the entire cellular mechanism within a cell or organism. Secondly, MOTIV provides systemic approach to discover the target protein of bioactive small molecule. With the chemical genomics and proteomics approach of target identification methods, various target protein candidates are identified. Then network analysis and validations of these candidates result in identifying the biologically relevant target protein and cellular mechanism. Overall, the combination of phenotypic screening and MOTIV will provide an effective approach to discover new bioactive small molecules and their target protein and mechanism identification.

AB - For effective bioactive small molecule discovery and development into new therapeutic drug, a systematic screening and target protein identification is required. Different from the conventional screening system, herein phenotypic screening in combination with multi-omics-based target identification and validation (MOTIV) is introduced. First, phenotypic screening provides visual effect of bioactive small molecules in the cell or organism level. It is important to know the effect on the cell or organism level since small molecules affect not only a single target but the entire cellular mechanism within a cell or organism. Secondly, MOTIV provides systemic approach to discover the target protein of bioactive small molecule. With the chemical genomics and proteomics approach of target identification methods, various target protein candidates are identified. Then network analysis and validations of these candidates result in identifying the biologically relevant target protein and cellular mechanism. Overall, the combination of phenotypic screening and MOTIV will provide an effective approach to discover new bioactive small molecules and their target protein and mechanism identification.

UR - http://www.scopus.com/inward/record.url?scp=84857921370&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857921370&partnerID=8YFLogxK

U2 - 10.1016/j.bmc.2011.11.021

DO - 10.1016/j.bmc.2011.11.021

M3 - Article

C2 - 22153994

AN - SCOPUS:84857921370

SN - 0968-0896

VL - 20

SP - 1922

EP - 1928

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

IS - 6

ER -

Identification and validation of bioactive small molecule target through phenotypic screening

Abstract

Bibliographical note

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this